InsidersTradesSigma
아이진 Stock: price and insider trades · South Korea · DART (FSS)
Track the 아이진 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 아이진 has published 72 insider filings. Market capitalisation: €64.4bn. The latest transaction was reported on 22 June 2026 (Purchase). Among the most active insiders: 한국비엠아이. The full history is accessible without an account.
71
Insider Decl.
n/a
Thresholds
n/a
40 ops.
Buy Volume
n/a
2 ops.
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,497 of 28,065 companies
20.9
score / 100
Value13
Quality29
FCF yld-10%
Earn yld-22%
EV/EBITDA·
ROE-25%
Gross mgn31%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 June 2026
Declarations72 total
Other
Other(filed)
25 of 72 declarations
About 아이진
아이진 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.